🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
This study evaluates the efficacy and mechanism of internet-based cognitive...
Status
Completed
Location
Beijing Friendship Hospital
Start Date
2015-10
Trial ID
NCT02640716
Treatments Being Tested
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
Vaccines are one of our most effective public health tools but many who nee...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-04
Trial ID
NCT02057263
Treatments Being Tested
The purpose of this study is to evaluate the safety and immune response of ...
Status
Completed
Location
University of Rochester
Start Date
2000-11
Trial ID
NCT00133549
Treatments Being Tested
This is a randomized, double blind, placebo-controlled, single site, trial ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2021-09-27
Trial ID
NCT04966871
Treatments Being Tested
The aim of this study is to explore potential for reduction of incidence an...
Status
Completed
Location
Hospital General de Agudos Dr. Ignacio Pirovano
Start Date
2021-01-06
Trial ID
NCT04903184
Treatments Being Tested
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested